title: Does octreotide prevent L-asparaginase-associated pancreatitis in children with acute lymphoblastic leukaemia?
authors.forename: Sadao
authors.initials: S
authors.lastname: Tokimasa
authors.forename: Kazumi
authors.initials: K
authors.lastname: Yamato
mesh_terms: D000208:Acute Disease; D000970:Antineoplastic Agents / Q000009:adverse effects*; D001215:Asparaginase / Q000009:adverse effects*; D002648:Child; D002675:Child, Preschool; D004341:Drug Evaluation / Q000379:methods; D005260:Female; D005765:Gastrointestinal Agents / Q000627:therapeutic use; D006801:Humans; D008297:Male; D015282:Octreotide / Q000627:therapeutic use*; D010195:Pancreatitis / Q000517:prevention & control*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy*; D055502:Secondary Prevention
chemical_list: D000970:Antineoplastic Agents; D005765:Gastrointestinal Agents; D001215:Asparaginase; D015282:Octreotide